Federal Supply Schedule 36F79721D0249

CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies, holds a Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs awarded by the Department of Veterans Affairs through Veterans Integrated Service Network 12. The master contract, effective from September 30, 2021, through September 29, 2026, carries a ceiling value of $201,482,280 and was awarded without set-aside designation, reflecting CSL Behring's status as a large, foreign-owned enterprise. The contract establishes a multiple-award vehicle through which the Veterans Health Administration procures specialty pharmaceutical products on a firm fixed-price basis, with primary performance at CSL Behring's facility in King of Prussia, Pennsylvania. Under this master contract structure, the National Acquisition Center and various Veterans Integrated Service Networks have issued numerous delivery orders and blanket purchase agreements to support pharmaceutical procurement across VA medical facilities nationwide.

The primary products delivered under this contract vehicle are HAEGARDA (a C1 inhibitor treatment for hereditary angioedema) and related plasma-derived therapies, including Privigen, Hizentra, and Kcentra. Representative delivery orders reviewed span from November 2021 through September 2024, with individual order values ranging from approximately $33,000 to $391,583, predominantly for HAEGARDA formulations in varying unit strengths (2000 and 3000 units per vial). Additionally, a single-award Blanket Purchase Agreement with a $17,500,000 ceiling through September 29, 2026, and a smaller BPA valued at $113,280 specifically address HAEGARDA procurement to facilitate efficient ordering across Veterans Integrated Service Networks 7, 8, 19, 22, and 9. These contract vehicles enable the VA to maintain a reliable supply chain for critical medications treating rare and complex medical conditions, with task orders issued by individual VISNs and VA medical facilities to support healthcare delivery to veterans across the national VA network.